News

Biomarkers for progression and repair in MS: the key to developing treatments for progressive forms of MS

10 December 2013

Related News

4 November 2024

Results from the D-Lay MS study, presented at ECTRIMS 2024, appeared to offer contrasting findings to PrevANZ, yet both reinforce…

30 October 2024

CEO Rohan Greenland asks whether the Australian Government is doing enough to support MS research and neurological research more generally….
Read More
needle

Newsletter subscription

  • Enter your details

Biomarkers for progression and repair in MS: the key to developing treatments for progressive forms of MS